The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle

Molecular and Cellular Endocrinology
Erik J Henriksen, Mujalin Prasannarong

Abstract

The canonical renin-angiotensin system (RAS) involves the initial action of renin to cleave angiotensinogen to angiotensin I (ANG I), which is then converted to ANG II by the angiotensin converting enzyme (ACE). ANG II plays a critical role in numerous physiological functions, and RAS overactivity underlies many conditions of cardiovascular dysregulation. In addition, ANG II, by acting on both endothelial and myocellular AT1 receptors, can induce insulin resistance by increasing cellular oxidative stress, leading to impaired insulin signaling and insulin-stimulated glucose transport activity. This insulin resistance associated with RAS overactivity, when coupled with progressive ß-cell dysfunction, eventually leads to the development of type 2 diabetes. Interventions that target RAS overactivity, including ACE inhibitors, ANG II receptor blockers, and, most recently, renin inhibitors, are effective both in reducing hypertension and in improving whole-body and skeletal muscle insulin action, due at least in part to enhanced Akt-dependent insulin signaling and insulin-dependent glucose transport activity. ANG-(1-7), which is produced from ANG II by the action of ACE2 and acts via Mas receptors, can counterbalance the deleterious ...Continue Reading

References

Feb 1, 1975·Circulation Research·E G Erdös
Jan 1, 1992·DNA and Cell Biology·W C ProbstS C Sealfon
Aug 1, 1995·Journal of Cardiovascular Pharmacology·Y MorelA Golay
May 1, 1995·Hypertension·D J CampbellS L Skinner
Feb 1, 1995·Metabolism: Clinical and Experimental·E J Henriksen, S Jacob
Dec 1, 1994·Nature Genetics·A J Villar, R A Pedersen
Nov 1, 1995·Clinical and Experimental Hypertension : CHE·M SuzukiY Harano
Jul 22, 1999·The New England Journal of Medicine·P R Shepherd, B B Kahn
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Jul 21, 2000·The Journal of Clinical Investigation·G I Shulman
Aug 22, 2000·Diabetologia·J R ZierathH Wallberg-Henriksson
Sep 9, 2000·The New England Journal of Medicine·D S Bell
Nov 6, 2001·The American Journal of Cardiology·V J DzauUNKNOWN Working Group on Tissue Angiotensin-converting enzyme, International Society of Cardiovascular Pharmacotherapy
Jul 23, 2002·Journal of Applied Physiology·Erik J Henriksen
Jul 23, 2002·Journal of Applied Physiology·Tyson R KinnickErik J Henriksen
Sep 24, 2002·JAMA : the Journal of the American Medical Association·Sverre E KjeldsenUNKNOWN LIFE (Losartan Intervention for Endpoint Reduction) Study Group
Mar 15, 2003·The Journal of Biological Chemistry·Hiroyuki SanoGustav E Lienhard
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·Alun Jones, David R Woods
Jun 11, 2003·Diabetes, Obesity & Metabolism·E J Henriksen, S Jacob
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Robson A S SantosThomas Walther
Apr 8, 2004·American Journal of Physiology. Endocrinology and Metabolism·Vitoon SaengsirisuwanErik J Henriksen
Oct 21, 2004·American Journal of Physiology. Endocrinology and Metabolism·Mihaela C BlendeaJames R Sowers
Jan 20, 2005·American Journal of Physiology. Endocrinology and Metabolism·Julie A SlonigerErik J Henriksen

❮ Previous
Next ❯

Citations

Dec 18, 2012·Current Hypertension Reports·Patricia C Underwood, Gail K Adler
Oct 25, 2014·Reviews in Endocrine & Metabolic Disorders·Soo Lim, Robert H Eckel
Feb 3, 2016·Ageing Research Reviews·Thomas W Buford
Feb 3, 2016·Journal of Ayurveda and Integrative Medicine·Kottireddy SatyanarayanaJayaraman Selvaraj
May 20, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Masao Yoshizumi, Masanori Yoshizumi
Mar 13, 2015·Medicinal Research Reviews·Claudio Cabello-VerrugioFelipe Simon
Oct 9, 2014·Pflügers Archiv : European journal of physiology·Carla MenesesClaudio Cabello-Verrugio
Mar 15, 2016·Antioxidants & Redox Signaling·Daniela MacconiAriela Benigni
Feb 26, 2016·Archives of Endocrinology and Metabolism·Christian L HerreraLuis A Salazar
Jun 7, 2018·Physiological Reviews·Steven J ForresterSatoru Eguchi
Nov 12, 2016·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Yupaporn RattanavichitVitoon Saengsirisuwan
Apr 17, 2019·Current Hypertension Reviews·Alexandra KatsimardouVasilios Athyros
Jul 3, 2019·Biology of Sex Differences·Melissa C WhiteAmy C Arnold
Mar 5, 2016·International Journal of Molecular Medicine·Yuehua ZhouYu Zeng
Jan 4, 2017·The Journal of Clinical Investigation·Huaizhu Wu, Christie M Ballantyne
May 3, 2014·American Journal of Therapeutics·Robert W Barrons, J Andrew Woods
May 20, 2015·Clinical Science·María Gabriela MoralesClaudio Cabello-Verrugio
Nov 30, 2018·Current Vascular Pharmacology·Agnieszka Baranowska-Bik, Wojciech Bik
Aug 16, 2019·Bioscience Reports·Jia LiuJiyan Leng
Feb 23, 2020·Diabetology & Metabolic Syndrome·Jian ShouWei-Hua Xiao
Jul 19, 2019·Biology of Sex Differences·Melissa C WhiteAmy C Arnold
Jan 20, 2019·Intensive Care Medicine Experimental·Vanessa ZambelliGiacomo Bellani
Jun 24, 2020·Frontiers in Public Health·Francis M Finucane, Colin Davenport
Jul 25, 2018·Clinical Science·Eliete Dalla Corte FrantzAntonio Claudio Lucas Nobrega
Apr 3, 2020·International Journal of Molecular Sciences·Forough Jahandideh, Jianping Wu
Nov 25, 2020·Clinical Science·Koichi YamamotoHiromi Rakugi
Dec 16, 2020·Archives of Endocrinology and Metabolism·Simone Cristina Soares BrandãoEsdras Marques Lins
Aug 30, 2020·Journal of the American Medical Directors Association·Lorna CaulfieldMiles D Witham
May 21, 2021·Journal of Agricultural and Food Chemistry·Md Yousof AliImtiaz Khan
Oct 19, 2021·American Journal of Physiology. Endocrinology and Metabolism·Ruben RodriguezRudy M Ortiz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
Erik J Henriksen
Hypertension Research : Official Journal of the Japanese Society of Hypertension
Masaru Iwai, Masatsugu Horiuchi
© 2021 Meta ULC. All rights reserved